WO2000049990A3 - The process for manufacturing topical ophthalmic preparations without systemic effects - Google Patents
The process for manufacturing topical ophthalmic preparations without systemic effects Download PDFInfo
- Publication number
- WO2000049990A3 WO2000049990A3 PCT/IN2000/000008 IN0000008W WO0049990A3 WO 2000049990 A3 WO2000049990 A3 WO 2000049990A3 IN 0000008 W IN0000008 W IN 0000008W WO 0049990 A3 WO0049990 A3 WO 0049990A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- systemic effects
- topical ophthalmic
- ophthalmic preparations
- manufacturing
- manufacturing topical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL13882400A IL138824A0 (en) | 1999-02-03 | 2000-02-02 | Process for manufacturing topical ophthalmic preparations without systemic effects |
EA200000918A EA200000918A1 (en) | 1999-02-03 | 2000-02-02 | METHOD OF MANUFACTURING THE EYE DRUGS OF LOCAL APPLICATION WITHOUT GENERAL ACTIONS |
CA002326690A CA2326690A1 (en) | 1999-02-03 | 2000-02-02 | The process for manufacturing topical ophthalmic preparations without systemic effects |
APAP/P/2000/001977A AP2000001977A0 (en) | 1999-02-03 | 2000-02-02 | The process for manufacturing topical opthalmic preparations without systemic effects. |
EP00925571A EP1139970A2 (en) | 1999-02-03 | 2000-02-02 | The process for manufacturing topical ophthalmic preparations without systemic effects |
BR0004530-6A BR0004530A (en) | 1999-02-03 | 2000-02-02 | Process for manufacturing topical ophthalmic preparations without systemic effects |
AU44291/00A AU4429100A (en) | 1999-02-03 | 2000-02-02 | The process for manufacturing topical ophthalmic preparations without systemic effects |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN90BO1999 IN185228B (en) | 1999-02-03 | 1999-02-03 | |
IN90/BOM/99 | 1999-02-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000049990A2 WO2000049990A2 (en) | 2000-08-31 |
WO2000049990A3 true WO2000049990A3 (en) | 2001-07-26 |
Family
ID=11077485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2000/000008 WO2000049990A2 (en) | 1999-02-03 | 2000-02-02 | The process for manufacturing topical ophthalmic preparations without systemic effects |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1139970A2 (en) |
AP (1) | AP2000001977A0 (en) |
AU (1) | AU4429100A (en) |
BR (1) | BR0004530A (en) |
CA (1) | CA2326690A1 (en) |
EA (1) | EA200000918A1 (en) |
ID (1) | ID28121A (en) |
IL (1) | IL138824A0 (en) |
IN (1) | IN185228B (en) |
WO (1) | WO2000049990A2 (en) |
ZA (1) | ZA200006252B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8858961B2 (en) | 2000-07-14 | 2014-10-14 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
AU2005220199B2 (en) * | 2000-07-14 | 2007-03-08 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
NZ521185A (en) * | 2000-07-14 | 2005-02-25 | Allergan Inc | Compositions containing alpha-2-adrenergic agonist components |
DE10132876A1 (en) * | 2001-07-06 | 2003-01-30 | Medproject Pharma Entwicklungs | Two-phase, drop-onable hydrogels for use on the eye |
US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
ES2647618T3 (en) | 2004-05-25 | 2017-12-22 | Galderma Pharma S.A. | Compounds, formulations and procedures to treat or prevent inflammatory skin disorders |
EP2329849B1 (en) | 2009-11-18 | 2015-04-29 | Galderma Research & Development | Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
FR2977493B1 (en) | 2011-07-05 | 2014-02-14 | Galderma Res & Dev | NOVEL STABLE ANESTHETIC COMPOSITION FOR REDUCING SKIN REACTIONS |
WO2014127243A1 (en) | 2013-02-15 | 2014-08-21 | Allergan, Inc. | Sustained drug delivery implant |
WO2014150899A1 (en) * | 2013-03-15 | 2014-09-25 | Chapin Matthew J | Topical ophthalmic formulations for treating migraine |
US9421199B2 (en) | 2014-06-24 | 2016-08-23 | Sydnexis, Inc. | Ophthalmic composition |
WO2016172712A2 (en) | 2015-04-23 | 2016-10-27 | Sydnexis, Inc. | Ophthalmic composition |
US11382909B2 (en) | 2014-09-05 | 2022-07-12 | Sydnexis, Inc. | Ophthalmic composition |
US11052094B2 (en) | 2015-05-29 | 2021-07-06 | Sydnexis, Inc. | D2O stabilized pharmaceutical formulations |
GB202110420D0 (en) * | 2021-07-20 | 2021-09-01 | Rosemont Pharmaceuticals Ltd | Liquid pharmaceutical composition of clonidine |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD294174A5 (en) * | 1990-05-04 | 1991-09-26 | Sigrid Keipert | OPHTHALMIKA WITH RESET EFFECT AND A NEW PROCESS FOR THEIR MANUFACTURE |
WO1993000887A1 (en) * | 1991-07-10 | 1993-01-21 | Laboratoire Europhta S.A. | Polyacrylic acid based ophthalmic compositions |
WO1993002663A1 (en) * | 1991-07-30 | 1993-02-18 | Laboratoires Merck Sharp & Dohme-Chibret | Ophthalmic compositions based on polyhydric alcohols |
EP0801948A1 (en) * | 1996-04-15 | 1997-10-22 | Dr. GERHARD MANN chem.-pharm. Fabrik GmbH | Ophthalmic composition having prolonged residence time in the eye |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6056684B2 (en) * | 1977-11-07 | 1985-12-11 | 東興薬品工業株式会社 | eye drops |
-
1999
- 1999-02-03 IN IN90BO1999 patent/IN185228B/en unknown
-
2000
- 2000-02-02 AP APAP/P/2000/001977A patent/AP2000001977A0/en unknown
- 2000-02-02 ID IDW20002252A patent/ID28121A/en unknown
- 2000-02-02 EP EP00925571A patent/EP1139970A2/en not_active Withdrawn
- 2000-02-02 AU AU44291/00A patent/AU4429100A/en not_active Abandoned
- 2000-02-02 IL IL13882400A patent/IL138824A0/en unknown
- 2000-02-02 CA CA002326690A patent/CA2326690A1/en not_active Abandoned
- 2000-02-02 EA EA200000918A patent/EA200000918A1/en unknown
- 2000-02-02 WO PCT/IN2000/000008 patent/WO2000049990A2/en not_active Application Discontinuation
- 2000-02-02 BR BR0004530-6A patent/BR0004530A/en active Pending
- 2000-11-01 ZA ZA200006252A patent/ZA200006252B/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD294174A5 (en) * | 1990-05-04 | 1991-09-26 | Sigrid Keipert | OPHTHALMIKA WITH RESET EFFECT AND A NEW PROCESS FOR THEIR MANUFACTURE |
WO1993000887A1 (en) * | 1991-07-10 | 1993-01-21 | Laboratoire Europhta S.A. | Polyacrylic acid based ophthalmic compositions |
WO1993002663A1 (en) * | 1991-07-30 | 1993-02-18 | Laboratoires Merck Sharp & Dohme-Chibret | Ophthalmic compositions based on polyhydric alcohols |
EP0801948A1 (en) * | 1996-04-15 | 1997-10-22 | Dr. GERHARD MANN chem.-pharm. Fabrik GmbH | Ophthalmic composition having prolonged residence time in the eye |
Also Published As
Publication number | Publication date |
---|---|
IN185228B (en) | 2000-12-09 |
AU4429100A (en) | 2000-09-14 |
ZA200006252B (en) | 2001-11-29 |
EA200000918A1 (en) | 2001-10-22 |
IL138824A0 (en) | 2001-10-31 |
ID28121A (en) | 2001-05-03 |
EP1139970A2 (en) | 2001-10-10 |
WO2000049990A2 (en) | 2000-08-31 |
AP2000001977A0 (en) | 2000-12-31 |
BR0004530A (en) | 2001-04-03 |
CA2326690A1 (en) | 2000-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000049990A3 (en) | The process for manufacturing topical ophthalmic preparations without systemic effects | |
WO2003011226A3 (en) | Products and drug delivery vehicles | |
DE60135872D1 (en) | ABSACK PREVENTION OF ISOROUTS USED IN THE MANUFACTURE OF FLAT GLASS AFTER THE MELTING PROCESS | |
AU2002256420A1 (en) | System and process for providing institutional directed sponsored trading | |
EE03923B1 (en) | S-omeprazole in neutral form, process for its preparation and pharmaceutical compositions containing it | |
AU2001234466A1 (en) | Tunable indocyanine dyes for biomedical applications | |
HUP0303735A3 (en) | Pyrazole derivatives for treating hiv, pharmaceutical compositions containing them and process for their preparation | |
MXPA01011039A (en) | 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations. | |
HK1047584A1 (en) | Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process. | |
WO2002100437A3 (en) | Ophthalmic compositions comprising hyaluronic acid | |
AU2001292197A1 (en) | Highly branched water-soluble polyamine oligomers, process for their preparationand applications thereof | |
WO2004087043A3 (en) | Stable ophthalmic formulation containing an antibiotic and a corticosteroid | |
AU1368300A (en) | Cold-active beta galactosidase, the process for its preparation and the use thereof | |
AU2003297199A1 (en) | Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof | |
IT1305313B1 (en) | 3,4 - DIHYDRO- 6- BENZYL-4-OXOPYRIMIDINE REPLACED AND RELATED PROCESS OF PRODUCTION AND USE IN THE THERAPY OF HIV-1 INFECTIONS. | |
AU2001289729A1 (en) | Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof | |
WO2002074036A3 (en) | Substituted benzopyranones as telomerase inhibitors | |
AU3825700A (en) | Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines | |
FI20002102A0 (en) | The method of redemption / delivery of a product, service, payment and / or similar | |
CA2370125A1 (en) | Decorative cosmetic preparations | |
AU2002245979A1 (en) | Process for making protein delivery matrix and uses thereof | |
AU2001254812A1 (en) | 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations | |
WO2000069841A3 (en) | Benzofuranylaminoalcohols | |
WO2004078142A3 (en) | Compositions and methods for preventing and treating endotoxin-related diseases and conditions | |
WO2005013955A3 (en) | Topical composition comprising terbinafine and hydrocortisone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AU BA BB BG BR CA CN CR CU CZ EE GE HU ID IL IS KP KR LC LK LR LS LT LV MG MK MN MX NO PL RO SG SI SL TR TT UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09719704 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2326690 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000925571 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2000/009715 Country of ref document: MX Ref document number: 138824 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200000918 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2000-3761 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1200000931 Country of ref document: VN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000/06252 Country of ref document: ZA Ref document number: 200006252 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 508027 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20000818-A Country of ref document: HR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2000-3761 Country of ref document: CZ |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AU BA BB BG BR CA CN CR CU CZ EE GE HU ID IL IS KP KR LC LK LR LS LT LV MG MK MN MX NO PL RO SG SI SL TR TT UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWP | Wipo information: published in national office |
Ref document number: 2000925571 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000925571 Country of ref document: EP |